Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - Heyu Biological Technology Corp | f10q0920_heyubiological.htm |
| EX-32.1 - CERTIFICATION - Heyu Biological Technology Corp | f10q0920ex32-1_heyubio.htm |
| EX-31.2 - CERTIFICATION - Heyu Biological Technology Corp | f10q0920ex31-2_heyubio.htm |
| EX-31.1 - CERTIFICATION - Heyu Biological Technology Corp | f10q0920ex31-1_heyubio.htm |
Exhibit 32.2
Certification by the Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Wendy Li, Chief Financial Officer of Heyu Biological Technology Corporation (the “Company”), hereby certify to my knowledge that:
The quarterly report on Form 10-Q for the quarter ended September 30, 2020 of the Company fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 16, 2020
| /s/ Wendy Li | |
| Wendy Li | |
|
Chief Financial Officer (Principal Financial Officer) |